Image may be NSFW.
Clik here to view.
An international partnership that includes Seattle-based biotech Kineta Inc. has created a new company with a unique approach to accelerating the development of new drug candidates.
The new company, KPI Therapeutics, will act as both an investment group and a strategic hub to unify research and development efforts.
KPI doesn’t own any of the companies involved, but will allow them to unite their overlapping areas of research and develop an umbrella strategy for drug development.
It’s a unique…
Clik here to view.
An international partnership that includes Seattle-based biotech Kineta Inc. has created a new company with a unique approach to accelerating the development of new drug candidates.
The new company, KPI Therapeutics, will act as both an investment group and a strategic hub to unify research and development efforts.
KPI doesn’t own any of the companies involved, but will allow them to unite their overlapping areas of research and develop an umbrella strategy for drug development.
It’s a unique…
